Normand Blais

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 27

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

General Practice

Top Venues

Current oncology (Toronto, Ont.)

Neuro-oncology advances

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Rupp, Fiorella Fanton-Aita, Stephanie L Snow, Paul Wheatley-Price, Barbara L Melosky, Rosalyn A Juergens, Quincy Chu, Normand Blais, Shantanu O Banerji, Ryan Ng, Shoghag Khoudigian, Arushi Sharma, Phu Vinh On, Geoffrey Liu
Lorlatinib Effectiveness and Quality-of-Life in Patients with ALK-Positive NSCLC Who Had Failed Second-Generation ALK Inhibitors: Canadian Real-World Experience. Current oncology (Toronto, Ont.) 30 (7) (2023)
Jenny J Ko, Shantanu O Banerji, Normand Blais, Anthony Brade, Cathy Clelland, Devin Schellenberg, Stephanie L Snow, Paul Wheatley-Price, Ren Yuan, Barbara L Melosky
Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial. Current oncology (Toronto, Ont.) 30 (4) (2023)
James Tankel, Jonathan D Spicer, Quincy Chu, Pierre-Olivier Fiset, Biniam Kidane, Natasha B Leighl, Philippe Joubert, Donna Maziak, David Palma, Anna McGuire, Barbara L Melosky, Stephanie L Snow, Houda Bahig, Normand Blais
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process. Current oncology (Toronto, Ont.) 30 (12) (2023)
Jenny J Ko, Shantanu O Banerji, Normand Blais, Anthony Brade, Cathy Clelland, Devin Schellenberg, Stephanie L Snow, Paul Wheatley-Price, Ren Yuan, Barbara L Melosky
Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial. Current oncology (Toronto, Ont.) 30 (4) (2023)
Philip Wong, Laura Masucci, Marie Florescu, Marc-Emile Plourde, Valerie Panet-Raymond, Michel Pavic, Scott P Owen, Laurence Masson-Coté, Cynthia Ménard, Bertrand Routy, Mustapha Tehfé, Kristoff Nelson, François Guilbert, Olivier Boucher, Sareh Keshavarzi, Normand Blais, David Roberge
Phase II multicenter trial combining nivolumab and radiosurgery for NSCLC and RCC brain metastases. Neuro-oncology advances 5 (1) (2023)
Barbara L Melosky, Natasha B Leighl, David E Dawe, Normand Blais, Paul F Wheatley-Price, Quincy S-C Chu, Rosalyn A Juergens, Peter M Ellis, Alexander Sun, Devin Schellenberg, Diana N Ionescu, Parneet K Cheema
Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer. Current oncology (Toronto, Ont.) 30 (7) (2023)
James Tankel, Jonathan D Spicer, Quincy Chu, Pierre-Olivier Fiset, Biniam Kidane, Natasha B Leighl, Philippe Joubert, Donna Maziak, David Palma, Anna McGuire, Barbara L Melosky, Stephanie L Snow, Houda Bahig, Normand Blais
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process. Current oncology (Toronto, Ont.) 30 (12) (2023)
James Tankel, Jonathan D Spicer, Quincy Chu, Pierre-Olivier Fiset, Biniam Kidane, Natasha B Leighl, Philippe Joubert, Donna Maziak, David Palma, Anna McGuire, Barbara L Melosky, Stephanie L Snow, Houda Bahig, Normand Blais
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process. Current oncology (Toronto, Ont.) 30 (12) (2023)
James Tankel, Jonathan D Spicer, Quincy Chu, Pierre-Olivier Fiset, Biniam Kidane, Natasha B Leighl, Philippe Joubert, Donna Maziak, David Palma, Anna McGuire, Barbara L Melosky, Stephanie L Snow, Houda Bahig, Normand Blais
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process. Current oncology (Toronto, Ont.) 30 (12) (2023)
Jenny J Ko, Shantanu O Banerji, Normand Blais, Anthony Brade, Cathy Clelland, Devin Schellenberg, Stephanie L Snow, Paul Wheatley-Price, Ren Yuan, Barbara L Melosky
Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial. Current oncology (Toronto, Ont.) 30 (4) (2023)
Parneet K Cheema, Shantanu O Banerji, Normand Blais, Quincy S-C Chu, Rosalyn A Juergens, Natasha B Leighl, Adrian Sacher, Brandon S Sheffield, Stephanie L Snow, Mark Vincent, Paul F Wheatley-Price, Stephen Yip, Barbara L Melosky
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC. Current oncology (Toronto, Ont.) 30 (7) (2023)
James Tankel, Jonathan D Spicer, Quincy Chu, Pierre-Olivier Fiset, Biniam Kidane, Natasha B Leighl, Philippe Joubert, Donna Maziak, David Palma, Anna McGuire, Barbara L Melosky, Stephanie L Snow, Houda Bahig, Normand Blais
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process. Current oncology (Toronto, Ont.) 30 (12) (2023)
Rola El Sayed, Mustapha Tehfé, Normand Blais
Successful Treatment with Brigatinib after Alectinib-Induced Hemolytic Anemia in Patients with Metastatic Lung Adenocarcinoma-A Case Series. Current oncology (Toronto, Ont.) 30 (1) (2022)
Rola El Sayed, Mustapha Tehfé, Normand Blais
Successful Treatment with Brigatinib after Alectinib-Induced Hemolytic Anemia in Patients with Metastatic Lung Adenocarcinoma-A Case Series. Current oncology (Toronto, Ont.) 30 (1) (2022)
Rola El Sayed, Mustapha Tehfé, Normand Blais
Successful Treatment with Brigatinib after Alectinib-Induced Hemolytic Anemia in Patients with Metastatic Lung Adenocarcinoma-A Case Series. Current oncology (Toronto, Ont.) 30 (1) (2022)
Rola El Sayed, Mustapha Tehfé, Normand Blais
Successful Treatment with Brigatinib after Alectinib-Induced Hemolytic Anemia in Patients with Metastatic Lung Adenocarcinoma-A Case Series. Current oncology (Toronto, Ont.) 30 (1) (2022)
Rola El Sayed, Mustapha Tehfé, Normand Blais
Successful Treatment with Brigatinib after Alectinib-Induced Hemolytic Anemia in Patients with Metastatic Lung Adenocarcinoma-A Case Series. Current oncology (Toronto, Ont.) 30 (1) (2022)
Diana N Ionescu, Tracy L Stockley, Shantanu O Banerji, Christian Couture, Cheryl A Mather, Zhaolin Xu, Normand Blais, Parneet K Cheema, Quincy S-C Chu, Barbara L Melosky, Natasha B Leighl
Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer. Current oncology (Toronto, Ont.) 29 (7) (2022)
Rola El Sayed, Mustapha Tehfé, Normand Blais
Successful Treatment with Brigatinib after Alectinib-Induced Hemolytic Anemia in Patients with Metastatic Lung Adenocarcinoma-A Case Series. Current oncology (Toronto, Ont.) 30 (1) (2022)
Félix Blanc-Durand, Marie Florescu, Mustapha Tehfe, Bertrand Routy, Raafat Alameddine, Danh Tran-Thanh, Normand Blais
Improvement of EGFR Testing over the Last Decade and Impact of Delaying TKI Initiation. Current oncology (Toronto, Ont.) 28 (2) (2021)
Camille Gauvin, Vimal Krishnan, Imane Kaci, Danh Tran-Thanh, Karine Bédard, Roula Albadine, Charles Leduc, Louis Arthur Gaboury, Normand Blais, Mustapha Tehfe, Bertrand Routy, Marie Florescu
Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC. Current oncology (Toronto, Ont.) 28 (1) (2021)
Rola El Sayed, Normand Blais
Immunotherapy in Extensive-Stage Small Cell Lung Cancer. Current oncology (Toronto, Ont.) 28 (5) (2021)
D Gwyn Bebb, Shantanu Banerji, Normand Blais, Patrice Desmeules, Sharlene Gill, Andrea Grin, Harriet E Feilotter, Aaron R Hansen, Martin Hyrcza, Monika Krzyzanowska, Barbara Melosky, Jonathan Noujaim, Bibiana Purgina, Dean Ruether, Christine E Simmons, Denis Soulieres, Emina Emilia Torlakovic, Ming Sound Tsao
Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults. Current oncology (Toronto, Ont.) 28 (1) (2021)
Normand Blais, Jean-Philippe Adam, John Nguyen, Jean C Grégoire
Evaluation and Management of Dyslipidemia in Patients Treated with Lorlatinib. Current oncology (Toronto, Ont.) 28 (1) (2021)
Parneet K Cheema, Shantanu O Banerji, Normand Blais, Quincy S-C Chu, Patrice Desmeules, Rosalyn A Juergens, Natasha B Leighl, Brandon S Sheffield, Paul F Wheatley-Price, Barbara L Melosky
Canadian Consensus Recommendations on the Management of MET -Altered NSCLC. Current oncology (Toronto, Ont.) 28 (6) (2021)
Marc Carrier, Normand Blais, Mark Crowther, Petr Kavan, Grégoire Le Gal, Otto Moodley, Sudeep Shivakumar, Deepa Suryanarayan, Vicky Tagalakis, Cynthia Wu, Agnes Y Y Lee
Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus. Current oncology (Toronto, Ont.) 28 (6) (2021)
Normand Blais, Jean-Philippe Adam, John Nguyen, Jean C Grégoire
Evaluation and Management of Dyslipidemia in Patients Treated with Lorlatinib. Current oncology (Toronto, Ont.) 28 (1) (2021)